Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Cybin teams up with Osmind to advance Phase 3 psychedelic therapy for depression

    As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    MaaT Pharma submits EMA application for Xervyteg in graft-versus-host disease

    MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Revolutionizing omics and biopharma: Thermo Fisher Scientific’s latest instruments debut at ASMS 2025

    Thermo Fisher Scientific has unveiled a new suite of analytical [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    Fujifilm life sciences companies rebrand to strengthen end-to-end drug development solutions

    Fujifilm Corporation’s Life Sciences Group has rebranded its key companies [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    Faster equine respiratory disease testing with bioMérieux’s new Vetfire PCR panel

    With Vetfire, bioMérieux enters the veterinary PCR market with an [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Limula secures US patent for automated cell therapy manufacturing tech

    Limula has confirmed the granting of a core patent in [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Opinion & Events

    AI governance in pharmacovigilance: Marie Flanagan calls for safety-specific frameworks to safeguard patient risk

    The integration of artificial intelligence into pharmacovigilance is prompting a [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Cellares brings automated CAR-T manufacturing to Japan with first IDMO Smart Factory

    Cellares and Mitsui Fudosan have announced plans to establish Japan’s [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Huawei’s AI chip surge: Why the US may be losing ground in the race for AI dominance

    As geopolitical tensions escalate between the US and China, the [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    Protagonist and Takeda present VERIFY data on rusfertide showing strong results in polycythemia vera

    Protagonist and Takeda have shared full 32-week results from the [...]

    May 5, 2026
Previous727374Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kairos Pharma and Bayer to evaluate ENV-105 combination in prostate cancer
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Lonza expands ADC drug product capacity in Switzerland
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Delivery & Formulation, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • Brain network dynamics may better explain psychiatric symptoms than diagnoses
    Categories: Central Nervous System, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top